Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Radian Group Inc    RDN

RADIAN GROUP INC (RDN)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 05/22 03:45:59 pm
16.21 USD   -0.73%
05/18RADIAN GROUP IN : Ex-dividend day for
FA
05/10RADIAN : Stockholders at Annual Meeting Re-Elect Directors, Approve ..
BU
05/07RADIAN : Announces Updated Pricing for MI Business
BU
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Radian Group Inc : Radian Group Inc. And Keryx Biopharmaceuticals News: (NYSE: RDN), (NASDAQ; KERX)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/22/2013 | 07:30am CEST

New York (April 22nd, 2013) - Radian Group Inc. (NYSE: RDN) announced that it will hold a conference call on Wednesday, May 1, 2013, at 11:00 a.m. Eastern time to discuss the company?s first quarter results, which will be announced prior to the market open on the same day.

Radian Group Inc. (RDN), headquartered in Philadelphia, provides private mortgage insurance and related risk mitigation products and services to mortgage lenders nationwide through its principal operating subsidiary, Radian Guaranty Inc. These services help promote and preserve homeownership opportunities for homebuyers, while protecting lenders from default-related losses on residential first mortgages and facilitating the sale of low-downpayment mortgages in the secondary market.

Find out more on RDN here:

http://www.wallstreetscoop.net/market-scan/?symbol=RDN


Keryx Biopharmaceuticals (NASDAQ:KERX) traded at $ 8.03 in the last session, which is +0.42 (5.52%). The stock has a Range of 7.58 - 8.06. The stock has a 52 week low and high of 1.30 - 9.98 respectively. The stock has a Market Cap of 655.90M. The stock traded a volume of 2.32M. The stock has a 30 day average volume of 2.74M.

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. It is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes.

Find out if KERX could maintain its gaining momentum here:

http://www.wallstreetscoop.net/market-scan/?symbol=KERX


About Us:

WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: www.wallstreetscoop.net/disclaimer/

Contact Info:
Thomas Greene
Wall Street Scoop
[email protected]
347-905-5009


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RADIAN GROUP INC
05/21RADIAN GROUP INC : Change in Directors or Principal Officers (form 8-K)
AQ
05/18RADIAN GROUP INC : Ex-dividend day for
FA
05/15RADIAN GROUP INC : Change in Directors or Principal Officers (form 8-K)
AQ
05/10RADIAN : Stockholders at Annual Meeting Re-Elect Directors, Approve Executive Co..
BU
05/09RADIAN : Part I. Item 2. Management's Discussion and Analysis of Financial Condi..
AQ
05/07RADIAN : Announces Updated Pricing for MI Business
BU
04/26RADIAN GROUP (NYSE : RDN) reported earnings of $0.59 per share beating Walls Str..
AQ
04/26RADIAN GROUP INC : Results of Operations and Financial Condition, Financial Stat..
AQ
04/26RADIAN GROUP INC : Radian Group Inc. to Host Earnings Call
AC
04/26RADIAN : 1Q Earnings Snapshot
AQ
More news
News from SeekingAlpha
05/21NMIH falls after introducing new risk-based pricing platform 
05/10Radian Group declares $0.0025 dividend 
05/07Doubts About Arch Capital's MI Business Have Created A Meaningful Valuation G.. 
05/04DAILY INSIDER RATINGS ROUND UP 5/1/1 : Pm, rdn, cfr, elox, safe, ontx, els, ebsb 
05/01FINANCIALS - TOP 5 GAINERS / LOSERS : 00 pm (05/01/2018) 
Financials ($)
Sales 2018 994 M
EBIT 2018 906 M
Net income 2018 525 M
Debt 2018 -
Yield 2018 0,06%
P/E ratio 2018 6,80
P/E ratio 2019 6,12
Capi. / Sales 2018 3,53x
Capi. / Sales 2019 3,37x
Capitalization 3 507 M
Chart RADIAN GROUP INC
Duration : Period :
Radian Group Inc Technical Analysis Chart | RDN | US7502361014 | 4-Traders
Technical analysis trends RADIAN GROUP INC
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 22,8 $
Spread / Average Target 39%
EPS Revisions
Managers
NameTitle
Richard G. Thornberry Chief Executive Officer & Director
Herbert Wender Non-Executive Chairman
J. Franklin Hall Chief Financial Officer & Executive Vice President
Eric R. Ray Senior Executive VP-Technology
David Charles Carney Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
RADIAN GROUP INC-20.48%3 507
BERKSHIRE HATHAWAY-0.33%484 210
TOKIO MARINE HOLDINGS INC4.34%36 656
THE TRAVELERS COMPANIES-4.27%35 093
THE ALLSTATE CORPORATION-8.69%33 363
SAMPO OYJ-5.04%28 330